S
00399
Starcoin Group
0.09
0.02+32.81%Closed16:08 11/18 HKT
OPEN/PREV CLOSE0.066/0.064
TODAY RANGE0.066-0.087
VOL121.35M
MARKET CAP182.14M
52 WEEK RANGE0.059-0.730
AVG VOL (3M)21.25M
% TURNOVER5.66%
TURNOVER9.33M
P/E (TTM)-0.527
% RANGE32.81%
EPS(TTM)-0.161
P/E(FORWARD)--
P/B-0.267
BVPS-0.318
DIVIDEND--
P/S85.000
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP182.14M
SHARES OUTSTANDING2.14B
NEXT EARNINGS--
FREE FLOAT2.14B
LOT SIZE5000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·09/29 09:53
Innovative Pharmaceutical Biotech Renames to Starcoin Group Limited
Reuters·08/29 12:34
Innovative Pharmaceutical Biotech Limited Conducted Annual General Meeting
Simply Wall St·08/05 23:02
Innovative Pharmaceutical Biotech Full Year 2025 Earnings: HK$0.20 loss per share (vs HK$0.068 profit in FY 2024)
Simply Wall St·07/20 00:16
Innovative Pharmaceutical Biotech Limited (HKG:399) surges 84%; individual investors who own 58% shares profited along with insiders
Simply Wall St·01/03 22:07
We Believe That Innovative Pharmaceutical Biotech's (HKG:399) Weak Earnings Are A Good Indicator Of Underlying Profitability
Simply Wall St·12/01/2024 01:33
One Innovative Pharmaceutical Biotech Insider Raised Stake By 15% In Previous Year
Reuters·11/29/2024 13:55
INNOVATIVE PHARMACEUTICAL BIOTECH H1 REVENUE HKD 3 MILLION
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.